Brand Name : OSELTASYS ORAL SUSPENSION
Composition : Oseltamivir Phosphate Oral Suspension 12 mg
Packing : 75ml
Quick EnquiryComposition : Oseltamivir Phosphate Oral Suspension 12 mg
Packing : 75ml
Quick EnquiryComposition (Each ml contains):
Oseltamivir Phosphate: 12 mg
Dosage Form: Oral Suspension
Therapeutic Class: Antiviral
Oseltamivir Phosphate Oral Suspension IP 12 mg: OSELTASYS ORAL SUSPENSION (Human Biolife) Oseltamivir phosphate is a broad-spectrum antiviral drug that is effective for the treatment and post-exposure prophylaxis of infections caused by influenza (the flu). It is part of the class of medications called neuraminidase inhibitors, which inhibit the virus and prevent damage.
The active component is oseltamivir phosphate 12 mg, a selective neuraminidase inhibitor. It is an enzyme located on the surface of the influenza virus (Influenza A and Influenza B). They contain an enzyme that is essential for the virus to leave infected cells and go on to infect healthy cells.
Oseltamivir phosphate inhibits this enzyme:
Therefore, OSELTASYS ORAL SUSPENSION not only shortens the period of recovery but also minimizes the risks of flu complications, including pneumonia, bronchitis, or hospitalization.
Treatment of Influenza A and B – Eases the severity of the flu and hastens recovery.
Prevention of Influenza – Effective when exposed to influenza during outbreaks.
Pediatric friendly – a suspension form that is easy to administer for children.
Minimizes complications—reduces risks of additional bacterial infections and respiratory problems.
Quick Action – Effective when consumed within 48 hours of symptoms of the flu.
Child-friendly: Syrup is a child-friendly dosage form to make it easy to swallow and to be dosed properly.
Fast Relief: Cuts down fever, sore throat, cough,, and body pain quickly.
Wide Coverage: Effective against influenza A and B virus.
Help stop the spread of the flu: Particularly a good asset during flu outbreaks.
Quality: Manufactured under strict WHO-GMP-certified standards, ensuring safety and efficacy.
OSELTASYS ORAL SUSPENSION is usually safe to take, but some people may experience some mild to moderate side effects.
The most frequent side effects of Oseltamivir Phosphate Oral Suspension are the following:
Serious side effects of Oseltamivir Phosphate Oral Suspension IP 12 mg have been reported.
However, in rare instances, serious reactions may occur and require immediate medical attention:
Influenza Treatment: Treatment will be best if initiated within 48 hours of onset of symptoms.
Pediatric Use: Dosage will depend on body weight; consult a pediatrician.
Adults & Adolescents: Typically given twice a day for 5 days.
Treatment of Influenza: Dosage may vary; typically, once a day for 10 days or longer after exposure.
Allergy Alert: Do not take if allergic to oseltamivir or excipients.
Renal Impairment: Dosage adjustment is needed in patients with renal disorders.
Pregnancy & Breastfeeding: Only use under a doctor's advice.
Children < 1 year: Safety not established; consult pediatrician.
Do Not Replace Flu Vaccine: Annual influenza vaccination should be used in place of this medicine.
Timely Use: Works best if taken early in the course of infection.
Q1. What is the use of the medicine Oseltamivir Phosphate Oral Suspension IP (12 mg)?
It is used to treat and prevent influenza (flu) infections caused by influenza A and B viruses.
Q2. Is it OK for children to take OSELTASYS ORAL SUSPENSION?
Yes, it is specially formulated so that children that can't swallow tablets can take it but it should be prescribed by a pediatrician.
Q3. When should I begin Oseltamivir after getting flu symptoms?
Treatment is best begun within 48 hours of the onset of symptoms.
Q4. Is OSELTASYS ORAL SUSPENSION safe during pregnancy?
May be used for benefit if risks are outweighed, under medical supervision.
Q5. Is it possible to stop getting the flu following exposure?
Yes, if taken after exposure, to decrease the risk of getting the flu.
Q6. If I forget to take my dose, what should I do?
Take as soon as possible, unless nearly time for the next dose. DO NOT double doses.
Let’s have a look at the product range available at Human Biolife India for the Monopoly business in India
2026 © Human Biolife India PVT. LTD.